These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 21944835

  • 1. Overweight is a risk factor for both erosive and non-erosive reflux disease.
    Savarino E, Zentilin P, Marabotto E, Bonfanti D, Inferrera S, Assandri L, Sammito G, Gemignani L, Furnari M, Dulbecco P, Savarino V.
    Dig Liver Dis; 2011 Dec; 43(12):940-5. PubMed ID: 21944835
    [Abstract] [Full Text] [Related]

  • 2. The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease.
    Savarino E, Marabotto E, Zentilin P, Frazzoni M, Sammito G, Bonfanti D, Sconfienza L, Assandri L, Gemignani L, Malesci A, Savarino V.
    Dig Liver Dis; 2011 Jul; 43(7):542-7. PubMed ID: 21376679
    [Abstract] [Full Text] [Related]

  • 3. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
    Shapiro M, Green C, Faybush EM, Esquivel RF, Fass R.
    Aliment Pharmacol Ther; 2006 Jan 15; 23(2):321-9. PubMed ID: 16393313
    [Abstract] [Full Text] [Related]

  • 4. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?
    Frazzoni M, Manno M, De Micheli E, Savarino V.
    Dig Liver Dis; 2006 Sep 15; 38(9):643-8. PubMed ID: 16627016
    [Abstract] [Full Text] [Related]

  • 5. The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn.
    Frazzoni M, Conigliaro R, Mirante VG, Melotti G.
    Neurogastroenterol Motil; 2012 Feb 15; 24(2):141-6, e87. PubMed ID: 21988704
    [Abstract] [Full Text] [Related]

  • 6. Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy.
    Savarino E, Tutuian R, Zentilin P, Dulbecco P, Pohl D, Marabotto E, Parodi A, Sammito G, Gemignani L, Bodini G, Savarino V.
    Am J Gastroenterol; 2010 May 15; 105(5):1053-61. PubMed ID: 19997095
    [Abstract] [Full Text] [Related]

  • 7. Pathophysiological characteristics of patients with non-erosive reflux disease differ from those of patients with functional heartburn.
    Frazzoni M, De Micheli E, Zentilin P, Savarino V.
    Aliment Pharmacol Ther; 2004 Jul 01; 20(1):81-8. PubMed ID: 15225174
    [Abstract] [Full Text] [Related]

  • 8. Association of body mass index with heartburn, regurgitation and esophagitis: results of the Progression of Gastroesophageal Reflux Disease study.
    Nocon M, Labenz J, Jaspersen D, Meyer-Sabellek W, Stolte M, Lind T, Malfertheiner P, Willich SN.
    J Gastroenterol Hepatol; 2007 Nov 01; 22(11):1728-31. PubMed ID: 17914941
    [Abstract] [Full Text] [Related]

  • 9. Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease.
    Savarino E, Gemignani L, Pohl D, Zentilin P, Dulbecco P, Assandri L, Marabotto E, Bonfanti D, Inferrera S, Fazio V, Malesci A, Tutuian R, Savarino V.
    Aliment Pharmacol Ther; 2011 Aug 01; 34(4):476-86. PubMed ID: 21671968
    [Abstract] [Full Text] [Related]

  • 10. Refractory GERD: increased body mass index is associated with persisting acid exposure but not hypersensitive esophagus or functional heartburn.
    Viazis N, Karamanolis GP, Anastasiou J, Keyoglou A, Vlachogiannakos J, Ladas SD, Karamanolis DG.
    Eur J Gastroenterol Hepatol; 2013 Dec 01; 25(12):1450-5. PubMed ID: 24047861
    [Abstract] [Full Text] [Related]

  • 11. [Non-erosive gastroesophageal reflux disease. Incidence of clinical forms, characteristics of esophageal exposure to acid and symptomatic correlations].
    Soto Pérez JC, Icaza ME, Vargas F, Valdovinos Díaz MA.
    Rev Gastroenterol Mex; 2003 Dec 01; 68(2):113-9. PubMed ID: 15127647
    [Abstract] [Full Text] [Related]

  • 12. Is ineffective oesophageal motility associated with reflux oesophagitis?
    Fornari F, Callegari-Jacques SM, Scussel PJ, Madalosso LF, Barros EF, Barros SG.
    Eur J Gastroenterol Hepatol; 2007 Sep 01; 19(9):783-7. PubMed ID: 17700264
    [Abstract] [Full Text] [Related]

  • 13. [Anxiety and depression related to the symptoms of gastroesophageal reflux disease].
    Xu ZJ, Duan LP, Wang K, Xia ZW, Lin SR.
    Zhonghua Yi Xue Za Zhi; 2005 Nov 30; 85(45):3210-5. PubMed ID: 16405842
    [Abstract] [Full Text] [Related]

  • 14. Relevance of ineffective esophageal motility and hyperactive acid sensitization in patients with gastroesophageal reflux.
    Hong SJ, Ko BM, Jung IS, Ryu CB, Moon JH, Cho JY, Kim JO, Lee JS, Lee MS, Shim CS, Kim BS.
    J Gastroenterol Hepatol; 2007 Oct 30; 22(10):1662-5. PubMed ID: 17559356
    [Abstract] [Full Text] [Related]

  • 15. Distinct clinical characteristics between patients with nonerosive reflux disease and those with reflux esophagitis.
    Wu JC, Cheung CM, Wong VW, Sung JJ.
    Clin Gastroenterol Hepatol; 2007 Jun 30; 5(6):690-5. PubMed ID: 17481961
    [Abstract] [Full Text] [Related]

  • 16. Non-erosive reflux disease (NERD)--acid reflux and symptom patterns.
    Martinez SD, Malagon IB, Garewal HS, Cui H, Fass R.
    Aliment Pharmacol Ther; 2003 Feb 15; 17(4):537-45. PubMed ID: 12622762
    [Abstract] [Full Text] [Related]

  • 17. Review article: the role of acid suppression in patients with non-erosive reflux disease or functional heartburn.
    DeVault KR.
    Aliment Pharmacol Ther; 2006 Mar 15; 23 Suppl 1():33-9. PubMed ID: 16483268
    [Abstract] [Full Text] [Related]

  • 18. The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy.
    Savarino E, Zentilin P, Tutuian R, Pohl D, Casa DD, Frazzoni M, Cestari R, Savarino V.
    Am J Gastroenterol; 2008 Nov 15; 103(11):2685-93. PubMed ID: 18775017
    [Abstract] [Full Text] [Related]

  • 19. [Pathological gastroesophageal reflux in patients with severe, morbid and hyper obesity].
    Csendes A, Burdiles P, Rojas J, Burgos A, Henríquez A.
    Rev Med Chil; 2001 Sep 15; 129(9):1038-43. PubMed ID: 11725467
    [Abstract] [Full Text] [Related]

  • 20. Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus.
    Emerenziani S, Sifrim D, Habib FI, Ribolsi M, Guarino MP, Rizzi M, Caviglia R, Petitti T, Cicala M.
    Gut; 2008 Apr 15; 57(4):443-7. PubMed ID: 17766596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.